Re: Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020 [0.03%]
亚历山大·科克斯，尼克拉斯·克吕默，约翰内斯·斯坦等。分子尿路上皮肿瘤细胞亚型在转移进化过程中保持稳定。 Eur Urol. 在线发表。https://doi.org/10.1016/j.eururo.2023.03.020
Mattias Höglund;Lund Bladder Cancer Group
Mattias Höglund;Lund Bladder Cancer Group
Re: Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer [0.03%]
关于监测、手术或放疗治疗前列腺癌15年结局的回复信
David Chang,Sree Appu,Shankar Siva
David Chang
Laura S Mertens,Géraldine Pignot,Luca Afferi et al.
Laura S Mertens et al.
For urology to be truly inclusive in the future, an equity-centred approach to pregnancy is required. Conditions for pregnant women and those caring for a newborn must be optimised to achieve this goal. The European Association of Urology c...
Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker Selection [0.03%]
尿路上皮癌中的免疫检查点抑制剂-未来方向和生物标志物选择
Joshua J Meeks,Peter C Black,Matthew Galsky et al.
Joshua J Meeks et al.
Context: Several recent phase 2 and 3 trials have evaluated the efficacy and toxicity of checkpoint inhibitor (CPI) therapy for urothelial carcinoma (UC) in the metastatic, localized muscle-invasive UC (MIUC), upper tract...
Continence Problems and Mental Health in Adolescents from a UK Cohort [0.03%]
英国青少年 continence 问题与心理健康状况
Katie Gordon,Naomi Warne,Jon Heron et al.
Katie Gordon et al.
Background: Adolescents with continence problems experience unique threats to their psychological well-being, but long-term mental health sequelae are unknown. ...
Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone Therapy [0.03%]
挽救性前列腺癌放射治疗的当代评估：放射治疗剂量、照射野大小和激素治疗的使用
Tommy Jiang,Luca F Valle,Amar U Kishan
Tommy Jiang
Studies have provided high-level evidence on various aspects of salvage radiation therapy (SRT) for recurrence of prostate cancer after radical prostatectomy, including field design, dose and fractionation, and additional hormonal therapy r...
Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes [0.03%]
基于睾丸精原细胞瘤男性患者的生殖系外显子组测序发现染色体分离和蛋白质定位基因的编码缺陷
Louise C Pyle,Jung Kim,Jonathan Bradfield et al.
Louise C Pyle et al.
Background: Testicular germ cell tumor (TGCT) is the most common cancer among young White men. TGCT is highly heritable, although there are no known high-penetrance predisposition genes. CHEK2 is associated with moderate ...
Reply to Zhipeng Mai, Weigang Yan, and Zhien Zhou's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023;83:561-70 [0.03%]
关于Mai ZP, Yan W, Zhou Z来信给编辑部的回信：一项全面的6个月前列腺癌患者赋权项目可降低接受根治性治疗的男性前列腺癌患者的心理痛苦：一项随机临床试验
Gabriela Ilie,Robert D H Rutledge
Gabriela Ilie
Randomized Controlled Trial
European urology. 2023 Aug;84(2):e48-e49. DOI:10.1016/j.eururo.2023.05.015 2023
Reply to Mattias Höglund's Letter to the Editor re: Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020 [0.03%]
马蒂亚斯·霍尔德根关于《亚历山大·科克斯，尼克拉斯基姆佩尔，约翰内斯施泰因等。分子尿路上皮肿瘤细胞亚型在转移进化过程中保持稳定》一文的信函回复
Niklas Klümper,Alexander Cox,Markus Eckstein
Niklas Klümper
Are PARP Inhibitors Ready for Prime Time in Metastatic Prostate Cancer? Maybe Not [0.03%]
PARP抑制剂准备好成为转移性前列腺癌的标准治疗了吗？可能还不行
Daniel A González-Padilla,José Daniel Subiela
Daniel A González-Padilla
While PARP inhibitors such as rucaparib and olaparib have shown activity in metastatic castration-resistant prostate cancer, they have failed to show a clear improvement in hard outcomes such as overall survival or quality of life. Because ...